Filters

63 Results

relevance


Cobra Sexual Energy

Class Action

Cobra Sexual Energy

Allegations: Falsely marketing supplements as “scientifically formulated to improve virility” without scientific evidence to support this claim

SlimFast Meal Replacement Products

Class Action

SlimFast Meal Replacement Products

Allegations: Misleadingly marketing products as clinically proven to provide weight loss and hunger control benefits without adequate scientific evidence to support such claims

Zicam Products

Class Action

Zicam Products

Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims

Neuriva

Class Action

Neuriva

Allegations: Falsely marketing Neuriva supplements as “clinically proven” to improve “brain performance” when the company has no scientific or clinical proof that the supplements or ingredients in them provide the…

Miracle Moo

Class Action

Miracle Moo

Allegations: Falsely marketing products as having “scientific validation” and making improper disease-treatment claims

IBgard Peppermint Oil

Class Action

IBgard Peppermint Oil

Allegations: Misleadingly marketing that the supplement is “clinically proven to Help Relieve Irritable Bowel Syndrome” without competent and reliable scientific evidence to support such claims

SlimFast Meal Replacement Products

Class Action

SlimFast Meal Replacement Products

Allegations: Falsely marketing that products are “clinically proven” to help consumers “lose weight & keep it off” when scientific evidence does not support such claims

Theraworx Muscle Cramp and Spasm Relief Foam

Class Action

Theraworx Muscle Cramp and Spasm Relief Foam

Allegations: Misleadingly marketing products as clinically proven to relieve pain and prevent cramps and spasms when none of the studies offered by the company support such claims

VSL#3 Probiotic Medical Food

Class Action

VSL#3 Probiotic Medical Food

Allegations: Misleadingly using “VSL#3” in marketing after defendants lost the right to sell the proprietary formulation in 2016 and began selling an inferior formulation that had not been proven effective

Show More